gender, age
Item
1. male or female 50 years of age or greater.
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
diagnosis, hypertension, elevated pulse pressure
Item
2. diagnosed with systolic hypertension (systolic blood pressure >140 mm hg and (less than or equal to) 200 mm hg, and a diastolic blood pressure (less than or equal to) 95 mm hg) and elevated pulse pressure (systolic blood pressure [sbp] minus diastolic blood pressure [dbp] greater than 60 mm hg).
boolean
C0011900 (UMLS CUI [1,1])
C0020538 (UMLS CUI [1,2])
C0011900 (UMLS CUI [2,1])
C0855323 (UMLS CUI [2,2])
ejection fraction
Item
3. normal left ventricular function (ejection fraction >55%) at baseline (visit 3).
boolean
C0232174 (UMLS CUI [1])
physcial performance
Item
4. able to perform bicycle exercise.
boolean
C3714565 (UMLS CUI [1])
informed consent
Item
5. able to read, understand and sign the informed consent after the nature of the study has been explained.
boolean
C0021430 (UMLS CUI [1])
contraception, sexual sterilization, post-menopausal, negative serum pregnancy test
Item
6. if sexually active, the patient agrees to use reliable contraception while participating in this study. if a woman, is surgically sterilized or post-menopausal, or has a negative serum pregnancy test.
boolean
C0700589 (UMLS CUI [1])
C0038288 (UMLS CUI [2])
C0232970 (UMLS CUI [3])
C0430061 (UMLS CUI [4])
aortic stenosis, coronary artery disease, cerebrovascular accident, or peripheral vascular disease
Item
1. aortic stenosis, prior known coronary artery disease (including myocardial infarction), cerebrovascular accident, or peripheral vascular disease.
boolean
C0003507 (UMLS CUI [1])
C1956346 (UMLS CUI [2])
C0038454 (UMLS CUI [3])
C0085096 (UMLS CUI [4])
uncontrolled hypertension
Item
2. uncontrolled hypertension (sbp > 200/ dbp > 95 mm hg).
boolean
C1868885 (UMLS CUI [1])
atrial fibrillation, diabetes mellitus or chronic lung disease
Item
3. atrial fibrillation, diabetes mellitus treated with insulin, or chronic lung disease.
boolean
C0004238 (UMLS CUI [1])
C0011849 (UMLS CUI [2])
C0746102 (UMLS CUI [3])
comorbidity
Item
4. any additional condition(s) which, in the opinion of the investigator, would prohibit the patient from completing the study, or not be in the best interest of the patient.
boolean
C0009488 (UMLS CUI [1])
nitrates, change in antihypertensive medication
Item
5. treatment with nitrates, or a change in antihypertensive medications within the last 1 month.
boolean
C0028125 (UMLS CUI [1])
C0580105 (UMLS CUI [2,1])
C0585941 (UMLS CUI [2,2])
investigational drug
Item
6. treatment with any investigational drug within 1 month prior to study drug administration.
boolean
C0013230 (UMLS CUI [1])
exposure to alagebrium
Item
7. previous exposure to alagebrium.
boolean
C0332157 (UMLS CUI [1,1])
C0913630 (UMLS CUI [1,2])
ast, alt
Item
8. ast (sgot) or alt (sgpt) > 2x normal limit.
boolean
C0004002 (UMLS CUI [1])
C0001899 (UMLS CUI [2])
serum creatinine
Item
9. serum creatinine > 2.0 ng/ml.
boolean
C0201976 (UMLS CUI [1])
smoking
Item
10. cigar/cigarette smoking.
boolean
C0543414 (UMLS CUI [1])
smokeless tobacco or nicotine-containing products, caffeine, alcohol, or antioxidants
Item
11. necessity to use smokeless tobacco or nicotine-containing products, or to consume caffeine, alcohol, or antioxidants starting at midnight prior to study clinic visits. note: water is allowed ad libitim.
boolean
C0040338 (UMLS CUI [1])
C0006644 (UMLS CUI [2])
C0001948 (UMLS CUI [3])
C0003402 (UMLS CUI [4])
positive drug screen
Item
12. positive drug screen.
boolean
C0743295 (UMLS CUI [1])